COMBINED SODIUM FLUORIDE AND CALCIUM CITRATE THERAPY IN OSTEOPOROSIS

氟化钠和柠檬酸钙联合治疗骨质疏松症

• 批准号: 6278713
• 负责人: KHASHAYAR SAKHAEE
• 金额: $ 2.47万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6278713
• 关键词: calcium; citrates; clinical research; clinical trials; combination chemotherapy; fluorine; human subject; human therapy evaluation; metabolism disorder chemotherapy; osteoporosis; skeletal disorder chemotherapy; slow release drug; sodium

The purpose is to determine whether or not the amount of bone in persons suffering from osteoporosis can be increased using a combination of slow release sodium fluoride and calcium citrate. Since this is a non- randomized study, only previously entered patients continue to be studied. New patients are entered into the randomized trials underway via sister projects.

其目的是确定人的骨量是否 患有骨质疏松症可以增加使用的组合缓慢 释放氟化钠和柠檬酸钙。 因为这是一个非- 随机化研究中，只有先前入组的患者继续接受 研究了 新的病人进入正在进行的随机试验 通过姐妹项目。